Public records unearthed by whistleblower, Dr. Leonard G. Horowitz, author of the internationally acclaimed text, Emerging Viruses: AIDS & Ebola–Nature, Accident or Intentional? (Tetrahedron, 1998), evidence heavy investments in an enterprise conducting experiments gone wrong using genetically-modified mosquitoes. Discoveries incriminate NYTimes billionaire owner Carlos Slim and his allied investors in Oxitec/Intrexon biotechnology firms.
“The New York Times has been caught red handed concealing their conflicting interest and emergence of the Zika virus from an experiment conducted in Brazil in 2014 using genetically-modified (GM) mosquitoes loosed by the Oxitec Company over which financial control is leveraged by Slim’s investment bankers,” explained Dr. Horowitz.
According to company records, Oxytec manufactured the GM insects tested in Brazil in 2014, along with dengue vaccine partners in Oxford University’s ISIS innovations, also funded by BlackRock and Evercore Company private equity investors.
CIRCUMSTANTIAL AND SCIENTIFIC EVIDENCE OF COMMERCIAL CRIME
In 1947, the original Zika virus was isolated from a rhesus monkey in Uganda by Rockefeller financed researchers. The Ugandan government at that time was under British control, and apparently under an Anglo-American (post WWII, Project Paperclip) contract with the CIA-administered aerospace and bioweapons organization called OTRAG. No other firm was capable of doing viral isolation studies in Western Uganda and Eastern Congo at that time. Once isolated, the “weak Zika virus” was then deposited with the Rockefeller Foundation, although it is apparent that Oxford Univ. engaged the secret enterprise with great interest.